News and Media
News and Media
Valerio Therapeutics announces changes in the composition of its Board of Directors
November 26, 2025
Proposed merger between Valerio Therapeutics and its subsidiary Valour Bio
October 31, 2025
Publication of the Half Yearl Report 2025
October 29, 2025
Valerio Therapeutics announces the completion of a capital increase with cancellation of preferential subscription rights
October 15, 2025
Transactions on the share capital of Valerio Therapeutics to restructure part of its liabilities
July 22, 2025
Resumption of trading from July 10, 2025
July 10, 2025
Publication of the Annual Report 2024
July 9, 2025
Temporary suspension of trading effective 17 June 2025
July 9, 2025
Valerio Therapeutics’ Financial situation
June 17, 2025
Temporary transfer of Valerio Therapeutics shares to the Penalty Bench from 16 May 2025
May 22, 2025
Valerio Therapeutics announces the postponement of its 2024 annual results due to accounting issues related to its U.S. subsidiary.
May 22, 2025
Valerio Therapeutics announces governance changes following the board meeting of February 20, 2025
March 7, 2025
KEPLER CHEVREUX liquidity contract termination, February 27th, 2025
February 27, 2025
Strategic refocus, February 3rd, 2025
February 3, 2025
Meeting of the Board of Directors of Valerio Therapeutics S.A. on November 13, 2024
November 15, 2024
[wd_hustle id=”2″ type=”embedded”/]
